Quanterix (QTRX) Prices 2.65M Share Offering at $32/Share

Quanterix Corporation (Nasdaq: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced the pricing of its previously announced underwritten public offering of 2,651,108 shares of its common stock at a public offering price of $32.00 per share. All of the shares in the offering will be sold by Quanterix. Gross proceeds from the sale of the shares, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $84.8 million. Quanterix has also granted the underwriters a 30-day option to purchase up to an additional 397,666 shares of common stock, at the public offering price less underwriting discounts and commissions.

The offering is expected to close on August 11, 2020, subject to customary closing conditions.

SVB Leerink and Cowen are acting as joint bookrunning managers for the offering. Canaccord Genuity is acting as co-manager for the offering.

You May Also Be Interested In

• Quanterix Corp. (QTRX) PT Lowered to $3 at Canaccord
• Libra Energy Materials options two Quebec lithium projects near Cisco
• Quanterix Corp. (QTRX) PT Lowered to $3 at TD Cowen